Enhancing TAVR Program Value

Lessons for improving outcomes and efficiency for an evolving therapy

TAVR has seen significant transformation in a short period of time and has driven the widespread development of structural heart disease centers. Yet the market continues to evolve and present unique challenges and opportunities for programs to achieve value in TAVR care delivery.

This white paper reviews the latest market trends and clinical updates impacting TAVR, as well as strategies identified from advanced programs for enhancing TAVR programs to improve long-term sustainability and outcomes.

This is a preview of restricted content.

Full access to this content is reserved for Cardiovascular Roundtable members. Log in now or learn more about Cardiovascular Roundtable.